- Home
- HIFS vs ORIC Comparison
HIFS vs ORIC Comparison
Compare HIFS & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIFS
- ORIC
- Stock Information
- Founded
- HIFS 1834
- ORIC 2014
- Country
- HIFS United States
- ORIC United States
- Employees
- HIFS N/A
- ORIC N/A
- Industry
- HIFS Major Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- HIFS Finance
- ORIC Health Care
- Exchange
- HIFS Nasdaq
- ORIC Nasdaq
- Market Cap
- HIFS 603.3M
- ORIC 633.7M
- IPO Year
- HIFS N/A
- ORIC 2020
- Fundamental
- Price
- HIFS $270.14
- ORIC $8.37
- Analyst Decision
- HIFS
- ORIC Strong Buy
- Analyst Count
- HIFS 0
- ORIC 9
- Target Price
- HIFS N/A
- ORIC $18.75
- AVG Volume (30 Days)
- HIFS 10.5K
- ORIC 294.2K
- Earning Date
- HIFS 01-17-2025
- ORIC 11-12-2024
- Dividend Yield
- HIFS 0.92%
- ORIC N/A
- EPS Growth
- HIFS N/A
- ORIC N/A
- EPS
- HIFS 10.55
- ORIC N/A
- Revenue
- HIFS $58,408,000.00
- ORIC N/A
- Revenue This Year
- HIFS N/A
- ORIC N/A
- Revenue Next Year
- HIFS N/A
- ORIC N/A
- P/E Ratio
- HIFS $25.93
- ORIC N/A
- Revenue Growth
- HIFS N/A
- ORIC N/A
- 52 Week Low
- HIFS $150.11
- ORIC $6.33
- 52 Week High
- HIFS $300.00
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- HIFS 44.87
- ORIC 36.28
- Support Level
- HIFS $273.30
- ORIC $8.07
- Resistance Level
- HIFS $286.00
- ORIC $8.62
- Average True Range (ATR)
- HIFS 6.52
- ORIC 0.49
- MACD
- HIFS -1.91
- ORIC -0.17
- Stochastic Oscillator
- HIFS 14.04
- ORIC 14.29
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.